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Regulatory CD4 T (T reg) cells control immune responses to self-antigens and 
pathogens. However, where T reg cells act to curtail effector T cells in vivo 
and what stage of effector T cell activation or differentiation is targeted by 
T reg cells remain unknown. Furthermore, a requirement for direct effector 
T cell–T reg cell contact in vivo has not been ascertained. Varying answers to 
these important questions have been provided by several new studies.
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During the decade since their discovery, 
T reg cells have become major culprits 
for immunosuppression associated with 
chronic infection and cancer. At the same 
time, T reg cell defi  ciency has been in-
voked as a cause of pathogenic immune 
hyperreactivity and infl  ammation associ-
ated with various forms of autoimmunity 
and allergies. Numerous studies suggested 
that, in addition to responses to autoanti-
gens, commensal fl  ora, and environmen-
tal and tumor antigens, exuberant adaptive 
immunity to viruses, bacteria, parasites, 
and at least some aspects of innate immu-
nity are also kept in check by CD4+ T 
reg cells, which can be identifi  ed by ex-
pression of the forkhead transcription fac-
tor Foxp3 (1). These results suggest that 
many diff  erent cell types might be tar-
geted by T reg cells. Indeed, in vitro and 
in vivo studies have provided evidence 
that T reg cells can suppress activation, 
proliferation, diff   erentiation, and even 
eff  ector function of multiple immune cell 
types including CD4+ and CD8+ T cells, 
B cells, natural killer cells, and dendritic 
cells (DCs) (1–3). It is unclear, however, 
whether the same or diff  erent eff  ector 
mechanisms are used by T reg cells to 
control such a variety of cell types. Also 
unknown is whether the suppressive ac-
tion of T reg cells is executed in second-
ary lymphoid organs or at the site of 
infl  ammation or both. The latter ques-
tion is of immediate relevance to another 
question—the stage of activation and dif-
ferentiation of the cells that are subjected 
to T reg cell–mediated control.
Several potential mechanisms of T 
reg–mediated suppression have been 
suggested. The results of in vivo analysis 
favor the production of immunosup-
pressive cytokines such as TGF-β and 
interleukin (IL)-10 or cell–cell contact–
dependent suppression mediated by the 
inhibitory receptor CTLA-4. In con-
trast, according to the majority of stud-
ies (with some notable exceptions), in 
vitro suppression was shown to be inde-
pendent of IL-10, TGF-β, or CTLA-4, 
but required cell–cell contact (2, 4–8). 
An additional suppression mechanism 
entertained by several investigators is 
granzyme or perforin-dependent killing 
of “suppressed” cells by T reg cells (9, 
10). A limitation of the available in vivo 
studies is that they are subject to alterna-
tive interpretations, whereas the in vivo 
relevance of results obtained in in vitro 
systems is left open to question. Sev-
eral new in vivo studies have provided 
novel important information pertinent 
to the mechanisms of T reg cell–medi-
ated suppression operating in vivo.
Modifi  cation of migratory behavior 
of antigen-specifi  c T cells 
in the lymph nodes
To address some of the aforemen-
tioned outstanding questions, a study by 
Tadokoro et al. published in this   issue 
(p. 505) (11) and another recent joint 
study by Tang et al. published in Nature 
Immunology (12) used the increasingly 
popular technique of two-photon laser 
scanning microscopy to examine po-
tential interactions between T cell re-
ceptor (TCR) transgenic regulatory and 
nonregulatory T cells and antigen-bear-
ing DCs in lymph nodes.
In the Tadokoro et al. study, fl  uo-
rescently labeled naive T cells specifi  c 
for myelin basic protein (MBP) peptide 
Ac1-11 were introduced into TCR 
transgenic recipient mice containing or 
lacking T reg cells of the same specifi  c-
ity. The rate of migration of naive T 
cells was not aff  ected by T reg cells in 
the absence of the antigenic peptide. 
However, upon provision of MBP 
Ac1-11 peptide, a notable arrest of acti-
vated MBP-specifi  c T cells interacting 
with antigen-loaded DCs was observed 
in the absence of antigen-specifi  c T reg 
cells, whereas in the presence of T reg 
cells arrest of T cells was signifi  cantly 
diminished. Polyclonal CD4+CD25+ 
T reg cells were also capable of dimin-
ishing antigen-mediated arrest of acti-
vated T cells, albeit to a smaller degree 
as compared with antigen-specifi  c TCR 
transgenic T reg cells (11).
A similar suppressive eff  ect of T reg 
cells on the formation of stable clusters 
of diabetogenic T cells with DCs in iso-
lated pancreatic lymph nodes was re-
ported by Tang et al. (12). These 
investigators transferred diabetogenic 
TCR transgenic BDC2.5 T cells into 
nonobese diabetic (NOD) mice con-
taining endogenously generated T reg 
cells or into CD28−/− NOD mice, 
which were previously shown to have 
drastically diminished numbers of T reg 
cells (13). As in the Tadokoro study, 
cotransfers of naive BDC2.5 T cells 
with in vitro–expanded T reg cells ex-
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CD25+CD4+ T cells into CD28−/− 
NOD mice also relieved T cell activa-
tion-associated arrest (12).
Both MBP- and pancreatic antigen-
specifi  c T cells showed diminished cy-
tokine production in the presence of T 
reg cells in the lymph nodes. Notably, 
both studies failed to reveal stable T 
reg–T eff  ector cell couples or triplets 
formed by T reg cells, activated T ef-
fector cells, and antigen-presenting 
DCs; only T reg–DC and T eff  ector 
cell–DC interactions were registered.
One potential diffi   culty in interpret-
ing the set of experiments by Tadokoro 
et al. is that essentially all T cells in the 
recipient mice were specifi  c for a MBP 
peptide, which may lead to systemic 
production of cytokines and chemo-
kines in response to MBP. And inter-
pretation of the Tang et al. study is 
complicated by the large number of in 
vitro–expanded antigen-specifi  c T reg 
cells that were provided (11). Never-
theless, the very similar observations re-
ported in these two studies support the 
view that T reg cells exert their sup-
pressive action on DCs in secondary 
lymphoid organs, specifi  cally in drain-
ing lymph nodes where, via a yet un-
identifi   ed mechanism, they diminish 
the ability of DCs to form stable con-
tacts with autoreactive T cells and in-
duce their activation.
Although the data from the two im-
aging studies suggest an attractive model 
for T reg cell–mediated suppression, it 
seems likely that additional T reg cell–
mediated suppressive mechanisms are 
operational in vivo, as suggested by a 
recent report from Chen et al. (14). 
These investigators transferred infl  u-
enza virus hemagglutinin peptide (HA)-
specifi  c TCR transgenic T reg cells and 
naive HA-specifi   c CD8 T cells into 
mice bearing HA-expressing tumors. 
Although HA-specifi   c T reg cells in 
these experiments did not interfere with 
the expansion of HA-specifi  c CD8 T 
cells and their diff  erentiation into eff  ec-
tor cells expressing high levels of the ef-
fector molecules FasL, IFN-γ, granzyme 
B, and perforin, killing of antigen-ex-
pressing target cells by what seemed to 
be competent eff  ector CD8 T cells was 
blocked in the presence of T reg cells 
(14) (von Adrian and von Boehmer, 
personal communication). Notably, im-
paired TGF-β receptor signaling in 
HA-specifi  c CD8 T cells conferred re-
sistance to T reg–mediated suppression 
of cytolytic activity in vivo (14), in 
agreement with two recent reports (15, 
16). These results emphasize an inter-
play between suppressive action of T 
reg cells and TGF-β1 on cells of the 
immune system, which remains to be 
elucidated in mechanistic terms.
T reg cell–mediated control of effector 
T cells in the tissues
In addition to their ability to block the 
initiation of immune responses in the 
secondary lymphoid tissues, several re-
cently published papers indicate that 
Foxp3+ T reg cells also migrate to and 
function within nonlymphoid sites. 
There, they can eff  ectively dampen im-
mune responses directed toward both 
self- and foreign antigens. In contrast to 
the two-photon microscopy study re-
ported by Tang et al. (12), using the 
same BDC2.5 TCR transgenic model 
of type 1 diabetes, Chen et al. recently 
showed that islet antigen-specifi  c T reg 
cells had no eff  ect on the priming of di-
abetogenic T cells in the pancreatic 
lymph node (17). Instead, BDC2.5 T 
reg cells prevented diabetes by inhibit-
ing the function of eff  ector T cells only 
in the pancreatic islets. Although it re-
mains unclear as to why such diff  ering 
results were obtained in two studies 
  using the same TCR transgenic model 
of autoimmune diabetes, utilization of 
CD28−/− rather than Foxp3 mutant 
NOD mice as T reg cell–deprived re-
cipients and diff  erences in the numbers 
and activation status of the transferred T 
reg cells might account for the diff  ering 
outcome of these studies.
Similarly to the study by Chen et al. 
(17), Belkaid et al. demonstrated several 
years ago that T reg cells in the skin 
dampen the immune response to the par-
asite Leishmania major during cutaneous 
infection (18). Indeed, T reg cell accu-
mulation in the skin is impaired in mice 
defi  cient for the integrin αE (CD103), 
and this renders otherwise susceptible 
BALB/c mice resistant to parasite infec-
tion (19). Susceptibility is restored by 
addition of wild-type T reg cells, 
demonstrating that local paucity of T reg 
cells results in enhanced parasite clear-
ance. In this issue (p. 777), this group 
takes this work further in a series of ex-
periments indicating that during L. major 
infection T reg cells in the dermis and 
draining lymph node are not self-reac-
tive, as might have been expected based 
on studies of T reg cell specifi  city, but in-
stead are largely parasite specifi  c (20).
Future questions
Together, these results raise several in-
triguing questions about the specifi  city 
of T reg cells and the functional mech-
anisms used by these cells to limit au-
toimmune and infl  ammatory  diseases. 
First, what are the functional mecha-
nisms used by T reg cells in lymphoid 
versus nonlymphoid tissues? From the 
imaging data, it appears that T reg cells 
do not directly interact with their targets 
within the lymphoid tissues. Instead, by 
interacting with antigen-presenting cells 
(APCs) they appear to restrict the ability 
of APCs to form stable interactions with, 
and thus prime, naive T cells. How-
ever, the mechanisms used to dampen 
infl  ammatory responses mediated by ef-
fector T cells in nonlymphoid tissues are 
likely to be quite distinct. Here, there 
may be a role for antiinfl  ammatory cy-
tokines such as TGF-β and IL-10 in 
blocking the recruitment and activation 
of proinfl  ammatory lymphoid and my-
eloid cells. Consistent with this idea, an 
increased level of mRNAs encoding 
these cytokines was found in pancreas-
  infi  ltrating T reg cells (17). Therefore, 
T reg cell localization in lymphoid ver-
sus nonlymphoid compartments may 
help explain the confl  icting data regard-
ing the eff  ector mechanisms that T reg 
cells use in vivo.
In addition, the signals that direct T 
reg cell migration to nonlymphoid tis-
sues remain to be identifi  ed. Eff  ector 
T cells acquire the ability to migrate to 
nonlymphoid sites as they reprogram 
their homing receptor expression during 
their initial activation in the secondary 
lymphoid tissues. Importantly, this re-
programming requires not only antigen 
recognition, but also   proinfl  ammatory 
signals associated, for example, with COMMENTARY
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microbial infection. T reg cells may 
undergo a similar phenotypic and func-
tional diff  erentiation. This leads to a 
model in which, under noninfl  amma-
tory conditions, T reg cells in the sec-
ondary lymphoid organs can prevent 
initiation of T cell responses by keeping 
APCs “turned off  ,” thus inhibiting suc-
cessful T cell priming (Fig. 1 A). [ID]FIG1[/ID] Strong 
proinfl  ammatory stimuli can overcome 
this regulation. Under these conditions, 
activated T reg cells migrate to nonlym-
phoid tissues, where they dampen eff  ec-
tor responses, preventing collateral tissue 
damage and infl  ammation that can result 
in lasting tissue damage caused by exces-
sive tissue remodeling or autoimmunity.
Finally, the question remains as to 
how T reg cells specifi  c for foreign an-
tigens develop. Several studies based on 
TCR transgenic mice that also express 
self-antigen led to the notion that Foxp3 
expression is induced in a subset of self-
reactive T cells that escapes negative 
  selection during thymic development 
(21, 22). This is further supported by 
the analysis of the TCR repertoire of 
Foxp3+ T reg cells, which showed that 
these cells are inherently self-reactive 
(23, 24). One possibility is that the L. 
major–specifi  c T reg cells in the study 
by Suffi   a et al. diff  erentiated from anti-
gen-specifi   c nonregulatory T cells by 
acquiring Foxp3 expression upon en-
counter with the cognate antigen in the 
periphery under tolerogenic conditions. 
However, adoptive transfer experi-
ments using congenically marked pre-
cursors of eff   ector T cells and T reg 
cells demonstrated that the eff  ector cells 
failed to appreciably up-regulate Foxp3 
expression during L. major infection and 
that the parasite-specifi   c T reg cells 
were derived from “naturally occur-
ring” T reg cells found in the periphery 
of uninfected mice (20). This raises the 
possibility that thymic development and 
peripheral maintenance of T reg cells 
specifi   c for foreign antigen such as 
L. major may be driven by recognition 
of cross-reactive self-antigens. Molecular 
identifi   cation of self- and pathogen-
  derived peptides recognized by these T 
reg cells, and a detailed analysis of the 
functional consequences of engagement 
of their TCRs by these ligands should 
shed light not only on development of 
these cells but also on the functional 
mechanisms they use to limit exuberant 
immune responses in the context of in-
fection and autoimmunity.
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